Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study

Background Anti-programmed cell death protein 1 (PD-1) immunotherapy has revolutionized the treatment of stage III and IV melanoma. Real-world data on its resistance is needed to facilitate the development of combinatorial approaches to overcome anti-PD-1 resistance.Objectives To characterize anti-P...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Carola Berking, Jessica C Hassel, Caroline Robert, Marcin Dzienis, Sarah Danson, Bhumsuk Keam, Miso Kim, Tae Min Kim, Stephane Dalle, Ricky Frazer, Dirk Debus, Ryan J Sullivan, Elizabeth M Gaughan, Christoffer Gebhardt, Nawab Qizilbash, Philippe Saiag, Julie Charles, Kavita Gandhi, Thierry Lesimple, Clemens Krepler, Salma Alam, Ruixuan Jiang, Markus Vincent Heppt, Glenn Geidel, Koung Jin Suh, Tessa Davies, Yu Jung Kim, James M Isaacs, Aparna D Rao, Ignacio Mendez, Maria Wei, Alexandra So, Xiaochen Zhong, Inga Hansen, Lina Hildebrandt, Alicia Delibes, Rosemarie Barnett, Irene M Shui, Xiang-Lin Tan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2026-03-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/14/3/e014564.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!